TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | -0 | -3 | 3 | 8 | 14 | 42 | 11 |
| S | %wins | 75 | 100 | 25 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/9/07 15:07 | 2/8/07 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kozak Kenneth | OH | O | VP,Resea | S.d | -437 | 29.15 | 10 | -15 | -83 | 3 | D | 162 | 30 | 46 | 36 | 20 | 4 | -1 | -1 | 0 | -2 | -4 | 4 | 24 | 62 |
8/31/06 15:56 | 8/29/06 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kozak Kenneth | OH | O | VP,Resea | S.dm | -292 | 23.30 | 6 | -13 | -81 | 3 | D | 215 | 42 | 6 | -5 | 6 | 18 | 0 | 3 | 3 | -5 | 1 | 5 | 17 | 70 |
12/19/05 11:54 | 12/15/05 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kozak Kenneth | OH | O | VP Resea | S | -154 | 20.47 | 7 | -8 | -100 | 0 | D | 209 | 75 | 60 | 13 | -2 | 11 | 11 | -1 | -2 | -2 | 12 | 19 | 8 | 19 |
9/12/03 16:58 | 9/11/03 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kozak Kenneth | OH | O | VP | S | -55 | 10.18 | 1 | -5 | -100 | 0 | D | 115 | 78 | 36 | 4 | -3 | -7 | -6 | -2 | -2 | -4 | 1 | 4 | 7 | 18 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |